Arquivamento definitivo - Art. 33 da LPI
#11.1.1
04/08/2025
RPI 2831
Application data
Number
112023014128Type
Filing
Publication
PCT
US2022012599 The application was abandoned: examination was not requested within the 36 months following the 01/14/2022 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 04/08/2025. We update with every new RPI gazette, published weekly.
Applicants
SEAGEN INC.
US
Inventors
A. H. (pessoa física)
US
E. G. (pessoa física)
US
E. C. (pessoa física)
US
P. B. (pessoa física)
US
S. G. (pessoa física)
US
IPC Classification
Priority claims
US
63/138,360 · 01/15/2021
US
63/292,779 · 12/22/2021
Abstract
CONJUGADOS DE ANTICORPO-FÁRMACO IMUNOMODULATÓRIOS. A presente divulgação fornece, inter alia, conjugados de anticorpo-fármaco que são úteis no tratamento de várias doenças, como o câncer.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.1.1
04/08/2025
RPI 2831
#11.1
01/21/2025
RPI 2820
#1.3
10/31/2023
RPI 2756
#1.1
07/25/2023
RPI 2742
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.